Clinical Trial Update: Pars Plana Ex-Press Shunt in Vitrectomized Eyes [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for Pars Plana Ex-Press Shunt in vitrectomized eyes evaluating safety and efficacy in glaucoma patients, currently in Phase 1/Phase 2 wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Pars Plana Ex-Press Shunt

Snippet

Sponsor: Cairo University | Conditions: Glaucoma Secondary | Phase 1, Phase 2 | Status: UNKNOWN